C-reactive protein and white blood cell count increases in the first 24 hours after acute stroke

Cerebrovascular Diseases

Volumn 18, Issue 3, 2004, Pages 214-219

  Christensen, Hanne ^a   Boysen, Gudrun ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

C reactive protein; Stroke; Stroke outcome; Stroke severity; White blood cell count

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; STROKE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CEREBROVASCULAR ACCIDENT; HUMANS; LEUKOCYTE COUNT; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 4644330988     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079944     Document Type: Article

References (36)

1. Winbeck K, Kukla C, Poppert H, Conrad B, Conrad B, Sander D: Elevated C-reactive protein is associated with an increased intima to media thickness of the common carotid artery. Cerebrovasc Dis 2002;13:57-63.
2. Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-843.
3. Grau AJ, Buggle F, Becher H, Werle E, Hacke W: The association of leukocyte count, fibrinogen and C-reactive protein with vascular risk factors and ischemic vascular diseases. Thromb Res 1996;82:245-255.
4. Di Napoli M, Papa F, Bocola V: C-reactive protein in ischemic stroke: An independent prognostic factor. Stroke 2001;32:917-924.
5. Grau AJ, Buggle F, Steichen-Wiehn C, Heindl S, Banerjee T, Seitz R, et al: Clinical and biochemical analysis in infection related stroke. Stroke 1995;26:1520-1526.
6. Ember JA, del Zoppo GJ, Mori E, Thomas WS, Copeland BR: Polymorphonuclear leukocyte behaviour in a nonhuman primate focal ischaemia model. J Cereb Blood Flow Metab 1994;14:1046-1054.
7. Young B, Gleeson M, Cripps AW: C-reactive protein: A critical review. Pathology 1991;23:188-124.
8. Christensen H, Boysen G: Blood glucose increased early after stroke onset: A study on serial measurements. Eur J Neurol 2002;9:297-301.
9. Boysen G, Christensen H: Stroke severity determines body temperature in acute stroke. Stroke 2001;32:413-417.
10. Christensen H, Boysen G, Christensen E, Johannesen HH, Bendtzen K: Deteriorating ischaemic stroke: Cytokines, soluble cytokine receptors, ferritin, systemic blood pressure, body temperature, blood glucose, diabetes, stroke severity, and CT infarction-volume as predictors of deteriorating ischaemic stroke. J Neurol Sci 2002;201:1-7.
11. Christensen H, Meden P, Overgaard K, Boysen G: The course of blood pressure in acute stroke is related to the severity of the neurological deficits. Acta Neurol Scand 2002;106:142-147.
12. Lindenstrøm E, Boysen G, Christiansen LW, à Rogvi Hansen B, Nielsen PW: Reliability of Scandinavian Neurological Stroke Scale. Cerebrovasc Dis 1991;1:103-107.
13. Sandøe E, Sigurd B: Arrhythmia: A Clinical Electrocardiographic Guide. Bingen, Publishing Partners Verlag, 1991.
14. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, van Gijn J: Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604-607.
15. Muir KW, Weir CJ, Alwan W, Squire IB, Lees KR: C-reactive protein and outcome after ischemic stroke. Stroke 1999;30:981-985.
16. Anuk T, Assayan EB, Rotstein R, Fusman R, Zeltser D, Berliner S, et al: Prognostic implications of admission inflammatory profile in acute ischemic neurological events. Acta Scand Neurol 2002;106:196-199.
17. Di Napoli M, Papa F, Bocola V: Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke 2001;32:133-138.
18. Canova CR, Courtin C, Reinhart WH: C-reactive protein (CRP) in cerebrovascular events. Atheroclerosis 1999;147:49-53.
19. Winbeck K, Poppert H, Etgen T, Conrad B, Sander D: Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke 2002;33:2459-2464.
20. Kammersgaard LP, Jørgensen HS, Reith J, Nakayama H, Houth JG, Weber UJ, et al: Early infection and prognosis after acute stroke: The Copenhagen Stroke Study. J Stroke Cerebrovasc Dis 2001;10:217-221.
21. Rost NS, Wolf PA, Kelly-Hayes M, Silbershatz H, Massaro JM, D'Agostino RB, et al: Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack. The Framingham Study. Stroke 2001;32:2575-2579.
22. Ridker PM, Burning JE, Cook NR, Rifai N: Creactive protein, the metabolic syndrome, and risk of cardiovascular events: An 8-year followup of 14,719 initially healthy American women. Circulation 2003;107:391-397.
23. Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, et al: C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001;104:2886-2891.
24. Christensen H, Boysen G, Christensen E, Johannesen HH, Bendtzen K: Plasma cytokines in acute stroke. J Stroke Cerebrovasc Dis 2002;11:72-79.
25. Beamer NB, Coull BM, Clark WM, Briley DP, Wynn M, Sexton G: Persistent inflammatory response in stroke survivors. Neurology 1998;50:1722-1728.
26. Gillum RF, Ingram DD, Macuc DM: White blood cell count and stroke incidence and death: The NHANES I epidemiologic followup study. Am J Epidemiol 1994;139:894-902.
27. Bovill EG, Bild DE, Heiss G, Kuller LH, Lee MH, Rock R, et al: White blood cell counts in persons aged 65 years or more from the cardiovascular health study: Correlations with baseline clinical and demographic characteristics. Am J Epidemiol 1996;143:1107-1115.
28. Reith J, Jørgensen HS, Pedersen PM, Nakayama H, Raaschou HO, Jeppesen P, et al: Body temperature in acute stroke: Relation to stroke severity, infarct size, mortality and outcome. Lancet 1996;347:422-425.
29. Silvestrini M, Pietroiusti A, Troisi E, Franceschelli L, Piccolo P, Magrini A, et al: Leukocyte count and aggregation during the evolution of cerebral ischaemic injury. Cerebrovasc Dis 1998;8:305-309.
30. Suzuki S, Kelly RE, Dandapani BK, Reyes-Iglesias Y, Dietrich D, Duncan RC: Acute leukocyte and temperature response in hypertensive intracerebral hemorrhage. Stroke 1995;26:1020-1023.
31. Devaraj S, Xu DY, Jialal I: C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells. Circulation 2003;107:398-404.
32. Ross R: Atherosclerosis - An inflammatory disease. N Engl J Med 1999;340:115-126.
33. Telle DS: Salt and blood pressure revisited. BMJ 1996;312:1240-1241.
34. Dewey HM, Donnam GA, Freeman EJ, Sharples CM, Macdonell RAL, McNeil JJ, et al: Interrater reliability of the National Institutes of Health scale: Rating by neurologists and nurses in a community-based stroke incidence study. Cerebrovasc Dis 1999;9:323-327.
35. Côté R, Hachinski VC, Shurvell BL, Norris JW, Wolfson C: The Canadian Neurological Scale: A preliminary study in acute stroke. Stroke 1986;17:731-737.
36. Wardlaw JM, Dennis MS, Lindley RI, Sellar RJ, Warlow CP: The validity of a simple clinical classification of acute stroke. J Neurol 1996;243:274-279.